Proof of this are the various collaboration agreements signed in this event that took place in the Pabexpo enclosure as part of the activities corresponding to the V International Convention Cuba Health 2025.
Of the most recent agreements are the contracts between companies of the Biocubafarma group and the state Belarusa Academpharm, who signed with Medsol for the creation of a mixed company between both parties.
The Belarus company also consolidated a representation contract with Pharmacuba for the health registration and marketing of products manufactured by the Caribbean biopharmaceutical industry.
In addition, the Drug Research and Development Center (CIDEM) also signed a letter of intent with said Belarusian company for the transfer of generic products technology developed by this Cuban institution.
On the other hand, the company Quality Pharma, of Peru signed a confidentiality agreement with the Cuban company Cimab SA with the aim of presenting the sanitary record of erythropoietin products in the presentations two thousand, four thousand and 10 thousand international units and filgrasim before the regulatory agency of that country.
CIMAB is dedicated to the commercialization of biopharmaceutical products, particularly monoclonal antibodies, therapeutic vaccines and other recombinant proteins for the diagnosis and treatment of cancer and other pathologies related to the immune system.
In the context of the XVI Fair, Cuba and Mexico presented an anesthesia unit and the joint work for the manufacture of the first tomograph by impedance included in a mechanical fan.
According to Ricardo Ballesteros, general director of the Mexican company Gatsimed, in 2024, cooperation began in projects that seek to take advantage of their entity’s abilities, Combiomed Digital Medical Technology and the Cuba Neurosciences Center, the latter belonging to Biocubafarma, to develop new markets with comprehensive solutions focused on health.
In addition to the manufacture of high complexity and performance equipment, the Alliance also focuses on providing platforms that contribute well -being to both health professionals and patients and families, based on the integral kit for primary health care, designed by Combiomed and in which other companies in the sector are involved, and for Gatsimed it is relevant, the Mexican representative said.
The manager announced that they currently venture into the generation of “Big Data” focused on medical use and that they plan to launch a telemedicine tool in the 2026 Biohabana Congress, although their employment will not mean the replacement of the health professional will facilitate decision making, from truthful and effective information in real time.
In the XVI International Health Fair for all, the conference “The role of Cuba in the Sanitary Autonomy of Latin America and the Caribbean” that focused the dialogue in a panel sponsored by Biocubafarma and the European Union was also developed.
Those present ratified that the European Union is the main technology supplier and a source of biocubafarma financing projects.
“This link tends a bridge for higher standard markets, where Cubans already make investments and create new capabilities,” said the president of the group, Mayda Mauri.
As for Latin America, the general director of the Finlay Vaccine Institute, Vicente Vérez Bencomo, referred to the common fund for the purchase of vaccines existing in the region and pointed out that only five percent of what is bought is produced in countries from the Bravo River to Patagonia.
“Those who most commercialize in that rotary fund are the large pharmaceuticals. With them, vaccines range between $ 15 and $ 20 per dose,” he warned.
If Cuba wants to insert in that market, you must compete so that most people can acquire low -cost medicines, Vérez said, and we must be able to produce 40 or 50 million doses per year, in order to compete with Asian prices.
For its part Judit Rius Sanjuan, director of the Department of Innovation of the Pan American Health Organization (PAHO), mentioned the importance of technical cooperation and pointed to Cuba as an inspiration of sustainable ecosystems based on public health. “That vision of health above all is what the region needs,” he said.
Expanding the construction of strategic alliances, mainly to identify new suppliers for the Cuban biofamaceutical industry, is one of the main purposes of biocubafarma during the XVI International Health Fair for all that this year was dedicated to China as a guest of honor, Mauri said.
/cdg
){kind=link}